Celgene Corp. has thwarted rival drugmakers eager to make cheaper versions of medicines for a form of blood cancer. Now administration officials are criticizing practices they say hold generics back.
Read more on NPR
Thursday, 17 May 2018
loobobilly News: How A Drugmaker Gamed The System to Keep Generic Competition Away
Labels:
Business
,
loobobillyNPR
Celgene Corp. has thwarted rival drugmakers eager to make cheaper versions of medicines for a form of blood cancer. Now administration officials are criticizing practices they say hold generics back.
Read more on NPR
Do You Like This Article
Get Subscribe to Free Email Updates!!
Popular Posts
-
Judge to dismiss Sarah Palin lawsuit against 'New York Times' A federal judge will dismiss Sarah Palin's defamation lawsuit agai...
-
Definers, an import from Washington to Silicon Valley, thrived with opposition research and a fishy campaign to push Apple’s C.E.O. for pres...
-
Police say package theft is up during the holiday shopping crush, but homeowners and retailers are striking back with cameras and other tech...
-
It can be tempting to hook up everything you love to the internet. But take a moment to appreciate some of the objects that can remain unplu...
-
In Indonesia’s traffic-ridden capital, one start-up makes it easy to get around — or not to have to in the first place. In Indonesia’s traff...
-
Newer versions of Google’s browser include a setting to easily mute web pages that would otherwise open with audio blaring. Newer versions o...
-
As Coal Jobs Fade, A Mining County Struggles To Redefine Itself Somerset County in southwestern Pennsylvania is deep coal country. For years...
